Primary practice
Davie Surgery - Ophthalmology - HOPD
Acute Care Hospital outpatient department · Bermuda Run, North Carolina
Find Dr. Melin's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Melin practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.
Dr. Melin's NPI, 1528042058, was assigned on November 29, 2005. Dr. Melin graduated from Wake Forest University School of Medicine in 1985. Dr. Melin holds North Carolina license 32792.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Melin's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.
Source: Dmand AI Affiliation Data
Dr. Melin's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.
Source: Dmand AI Affiliation Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melin practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Davie Surgery - Ophthalmology - HOPD | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Hematology and oncology is Dr. Melin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Melin is licensed in North Carolina.
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 20 Medicare services from Dr. Melin across 1 procedure code in 2024, all of them office visits, for 17 Medicare patients. Medicare paid $1,206 for them. Every service was in a facility, such as a hospital, rather than an office.
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Melin?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Melin and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 17 Medicare patients who saw Dr. Melin in 2024. The largest group is under 65, with 0 patients. 75% of them have cancer, and 71% have high cholesterol. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Melin's median patient age at 72, with 100% women.
CMS leaves out age groups with fewer than 11 patients.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 72
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Melin wrote 179 Medicare Part D claims for 38 patients. 85% of them were for generic drugs. CMS names the drug for 88 of them, across 4 drugs with 11 or more claims each, at $307,609 in total drug cost. In 2023, CMS named 87 claims across 3 drugs.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Drugs named by CMS: 4 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links Dr. Melin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Melin that name 1 trial.
Conditions in Dr. Melin's trials
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
CMS Open Payments shows 25 general payments to Dr. Melin from 12 drug and device companies from 2016 to 2025. Education make up the largest share, 55% of the total. Eli Lilly and Company paid the most, $645. It also lists 1 research payment totaling $161 in 2018, naming 1 clinical trial.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Melin graduated from Wake Forest University School of Medicine in 1985.
Source: Dmand AI Professional Profile Data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Susan Anitra Melin's NPI number is 1528042058. It was assigned on November 29, 2005, and it is active in the NPI Registry.
Dr. Susan Anitra Melin is a hematologist and oncologist in Advance, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Dr. Melin practices at 329 Nc Highway 801 N, Bermuda Run, NC 27006. Dr. Melin's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.
Dr. Melin holds North Carolina license 32792.
Yes. CMS data shows Dr. Melin billed Medicare for 20 services in 2024.
CMS counts 17 Medicare patients who saw Dr. Melin in 2024, with an average age of 74.
In 2024, Dr. Melin's most billed Medicare services were office visit, established patient (99214).
Dr. Melin graduated from Wake Forest University School of Medicine in 1985.
In 2024 Medicare Part D data, Dr. Melin's most prescribed drugs by claims were Letrozole, Anastrozole and Tamoxifen Citrate.
CMS Open Payments shows $2,329 in general payments to Dr. Melin from 12 companies from 2016 to 2025. The largest total came from Eli Lilly and Company.
Dr. Melin graduated from medical school in 1985, 41 years ago.
Dr. Melin has worked on 1 clinical trial.
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.